Lei Liu1, Zhen Wang2, Hui Gyu Park2, Chuang Xu3, Peter Lawrence2, Xueli Su4, Vasuki Wijendran5, W Allan Walker5, Kumar S D Kothapalli6, J Thomas Brenna7. 1. College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan 410128, China; Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA. 2. Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA. 3. Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA; College of Animal Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, Heilongjiang 163319, China. 4. Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA; Jingchu University of Technology, Jingmen, Hubei 448000, China. 5. Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Charlestow, MA, USA. 6. Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA. Electronic address: ksk25@cornell.edu. 7. Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA. Electronic address: jtb4@cornell.edu.
Abstract
BACKGROUND: Branched chain fatty acids (BCFA) are constituents of gastrointestinal (GI) tract in healthy newborn human infants, reduce the incidence of necrotizing enterocolitis (NEC) in a neonatal rat model, and are incorporated into small intestine cellular lipids in vivo. We hypothesize that BCFA are taken up, metabolized and incorporated into human fetal cells in vitro. METHODS: Human H4 cells, a fetal non-transformed primary small intestine cell line, were incubated with albumin-bound non-esterified anteiso-17:0, iso-16:0, iso-18:0 and/or iso-20:0, and FA profiles in lipid fractions were analyzed. RESULTS: All BCFA were readily incorporated as major constituents of cellular lipids. Anteiso-17:0 was preferentially taken up, and was most effective among BCFA tested in displacing normal (n-) FA. The iso BCFA were preferred in reverse order of chain length, with iso-20:0 appearing at lowest level. BCFA incorporation in phospholipids (PL) followed the same order of preference, accumulating 42% of FA as BCFA with no overt morphological signs of cell death. Though cholesterol esters (CE) are at low cellular concentration among lipid classes examined, CE had the greatest affinity for BCFA, accumulating 65% of FA as BCFA. BCFA most effectively displaced lower saturated FA. Iso-16:0, iso-18:0 and anteiso-17:0 were both elongated and chain shortened by ±C2. Iso-20:0 was chain shortened to iso-18:0 and iso-16:0 but not elongated. CONCLUSIONS: Nontransformed human fetal intestinal epithelial cells incorporate high levels of BCFA when they are available and metabolize them in a structure specific manner. These findings imply that specific pathways for handling BCFA are present in the lumen-facing cells of the human fetal GI tract that is exposed to vernix-derived BCFA in late gestation.
BACKGROUND:Branched chain fatty acids (BCFA) are constituents of gastrointestinal (GI) tract in healthy newborn humaninfants, reduce the incidence of necrotizing enterocolitis (NEC) in a neonatal rat model, and are incorporated into small intestine cellular lipids in vivo. We hypothesize that BCFA are taken up, metabolized and incorporated into human fetal cells in vitro. METHODS:HumanH4 cells, a fetal non-transformed primary small intestine cell line, were incubated with albumin-bound non-esterified anteiso-17:0, iso-16:0, iso-18:0 and/or iso-20:0, and FA profiles in lipid fractions were analyzed. RESULTS: All BCFA were readily incorporated as major constituents of cellular lipids. Anteiso-17:0 was preferentially taken up, and was most effective among BCFA tested in displacing normal (n-) FA. The iso BCFA were preferred in reverse order of chain length, with iso-20:0 appearing at lowest level. BCFA incorporation in phospholipids (PL) followed the same order of preference, accumulating 42% of FA as BCFA with no overt morphological signs of cell death. Though cholesterol esters (CE) are at low cellular concentration among lipid classes examined, CE had the greatest affinity for BCFA, accumulating 65% of FA as BCFA. BCFA most effectively displaced lower saturated FA. Iso-16:0, iso-18:0 and anteiso-17:0 were both elongated and chain shortened by ±C2. Iso-20:0 was chain shortened to iso-18:0 and iso-16:0 but not elongated. CONCLUSIONS: Nontransformed human fetal intestinal epithelial cells incorporate high levels of BCFA when they are available and metabolize them in a structure specific manner. These findings imply that specific pathways for handling BCFA are present in the lumen-facing cells of the human fetal GI tract that is exposed to vernix-derived BCFA in late gestation.
Authors: Charles C Oh; Michael Q Nguy; Dawn C Schwenke; Raymond Q Migrino; Kent Thornburg; Peter Reaven Journal: Biochem Biophys Res Commun Date: 2014-06-12 Impact factor: 3.575
Authors: Vasuki Wijendran; J T Brenna; Dong Hao Wang; Weishu Zhu; Di Meng; Kriston Ganguli; Kumar S D Kothapalli; Pilar Requena; Sheila Innis; W Allan Walker Journal: Pediatr Res Date: 2015-08-13 Impact factor: 3.756
Authors: Martina Wallace; Courtney R Green; Lindsay S Roberts; Yujung Michelle Lee; Justin L McCarville; Joan Sanchez-Gurmaches; Noah Meurs; Jivani M Gengatharan; Justin D Hover; Susan A Phillips; Theodore P Ciaraldi; David A Guertin; Pedro Cabrales; Janelle S Ayres; Daniel K Nomura; Rohit Loomba; Christian M Metallo Journal: Nat Chem Biol Date: 2018-10-16 Impact factor: 15.040
Authors: Ellen Looijesteijn; Rutger W W Brouwer; Ruud J W Schoemaker; Wilfred F J van IJcken; Yannis Manios; Laurien H Ulfman; Stephanie L Ham; Prescilla Jeurink; Eva Karaglani Journal: BMC Nutr Date: 2022-08-29
Authors: Victoria M Taormina; Allison L Unger; Morgan R Schiksnis; Moises Torres-Gonzalez; Jana Kraft Journal: Nutrients Date: 2020-09-20 Impact factor: 5.717